Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00724516|
Recruitment Status : Completed
First Posted : July 29, 2008
Last Update Posted : July 6, 2017
|Condition or disease||Intervention/treatment||Phase|
|Mammography Biopsy, Needle||Device: Novel Breast Compression Paddle||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Device Feasibility|
|Official Title:||Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography|
|Study Start Date :||June 2007|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2010|
Experimental: Novel Breast Compression Paddle
Women scheduled to undergo a breast mammography wire localization procedure will have a new breast compression paddle will be used Instead of using the regular wire localization mammography compression paddle.
Device: Novel Breast Compression Paddle
Instead of using the regular wire localization mammography compression paddle, a new breast compression paddle will be used. The new breast compression paddle is similar to a tennis racquet. It consists of crossing plastic strings that are strung tightly in a frame. The needle/wire can be inserted anywhere between the strings.
- Evaluate the newly designed breast compression paddle. [ Time Frame: 1 year ]To objectively determine if the functionality of this new breast compression paddle allows for easier access to the breast during wire localization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00724516
|United States, Michigan|
|University of Michigan Health System|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Caroline Blane, M.D.||University of Michigan Hospital|